Howard M. Gebel
Papers
1
Total Citations
2
H-Index
1
About
Dr. Howard M. Gebel is a pioneering immunologist whose career has been defined by transformative contributions to transplant immunology, particularly in the management of antibody-mediated rejection (AMR) and histocompatibility. His research has fundamentally reshaped how the field understands and treats sensitized transplant patients—those with pre-existing antibodies against donor organs. One of his landmark contributions is his work on regulatory frameworks for new antihumoral therapies, as highlighted in his 2011 paper (2 citations), which addressed the critical barriers to clinical trials for AMR treatments and fostered essential dialogue between scientists and the FDA. While his citation counts reflect focused, high-impact clinical guidance rather than broad volume, his influence is profound: he has been instrumental in developing desensitization protocols that allow incompatible transplants to succeed, saving countless lives. Dr. Gebel’s achievements include serving as a key advisor to national transplant organizations and authoring seminal guidelines on HLA antibody testing. For students and researchers, his work exemplifies how rigorous immunology can directly overcome life-threatening clinical challenges.
Research Focus
Key Achievements
Top Papers
- 1